Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Trinity Biotech Q4 Profit Rises

RELATED NEWS
Trade TRIB now with 

Trinity Biotech plc (TRIB: Quote) Monday reported fourth-quarter profit of $4.0 million or 18.4 cents per american depositary receipt, or ADR, rising from last year's $3.7 million or 16.6 cents per ADR.

Revenues for the quarter rose 4 percent to $20.0 million from $19.2 million last year due to higher HIV sales in Africa and USA. Point-of-care revenue increased 12.4 percent while clinical laboratory revenue rose 2.1 percent from last year.

Click here to receive FREE breaking news email alerts for Trinity Biotech plc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
After moving moderately lower in early trading on Monday, stocks have seen further downside as the trading day has progressed. With the drop on the day, the Dow has pulled back well off last Friday's record closing high. After reporting four consecutive monthly increases, the National Association of Realtors released a report on Monday showing an unexpected drop in U.S. existing home sales in the month of August. NAR said existing home sales fell 1.8 percent to a seasonally adjusted annual rate of 5.05 million in August. The European Central Bank remains ready to use additional unconventional tools to counter risks to the inflation outlook and to boost the euro area economy, ECB President Mario Draghi said on Monday. "The Governing Council remains fully determined to counter risks to the medium-term outlook for inflation," Draghi said in Brussels.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.